Literature DB >> 20870672

The cardiac renin-angiotensin system is responsible for high-salt diet-induced left ventricular hypertrophy in mice.

Philippe Le Corvoisier1, Christophe Adamy, Lucien Sambin, Bertrand Crozatier, Alain Berdeaux, Jean-Baptiste Michel, Luc Hittinger, JinBo Su.   

Abstract

AIMS: This study aimed to determine the role of the renin-angiotensin system (RAS) in high-salt (HS) diet-induced left ventricular hypertrophy (LVH). METHODS AND
RESULTS: Swiss mice were subjected to regular salt (RS) diet (0.6% NaCl), HS diet (4% NaCl), and HS plus irbesartan (50 mg/kg/day) or ramipril (1 mg/kg/day). After 8 weeks, arterial pressure was similar in all groups and similar to baseline, whereas left ventricle/body weight ratio was higher in HS mice than in RS mice (P < 0.005). There were also significant increases in collagen density, angiotensin-converting enzyme activity, angiotensin II type 1 receptor (AT1 receptor) density, and extracellular signal-regulated kinase (ERK1/2) phosphorylation in the left ventricle. Interestingly, increases in wall thickness and ERK1 phosphorylation were more marked in the septum than in the rest of the left ventricle. Irbesartan or ramipril treatment prevented LVH and the increase in ERK phosphorylation and reduced collagen content and AT1 up-regulation but up-regulated AT2 receptors.
CONCLUSION: In normal mice, HS diet induces septum-predominant LVH and fibrosis through activation of the cardiac RAS-ERK pathway, which can be blocked by irbesartan or ramipril, indicating a key role of the cardiac RAS in HS diet-induced LVH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20870672      PMCID: PMC3290525          DOI: 10.1093/eurjhf/hfq146

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  30 in total

1.  Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.

Authors:  X P Yang; Y H Liu; D Mehta; M A Cavasin; E Shesely; J Xu; F Liu; O A Carretero
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

2.  Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.

Authors:  C Pellieux; T Sauthier; J F Aubert; H R Brunner; T Pedrazzini
Journal:  J Hypertens       Date:  2000-09       Impact factor: 4.844

3.  The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.

Authors:  O F Bueno; L J De Windt; K M Tymitz; S A Witt; T R Kimball; R Klevitsky; T E Hewett; S P Jones; D J Lefer; C F Peng; R N Kitsis; J D Molkentin
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

4.  Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy.

Authors:  Y Takeda; T Yoneda; M Demura; I Miyamori; H Mabuchi
Journal:  Endocrinology       Date:  2000-05       Impact factor: 4.736

5.  High-salt diet during pregnancy and angiotensin-related cardiac changes.

Authors:  Yang Ding; Juanxiu Lv; Caiping Mao; Huiying Zhang; Aiqing Wang; Liyan Zhu; Hui Zhu; Zhice Xu
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

6.  Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis.

Authors:  V Robert; C Heymes; J S Silvestre; A Sabri; B Swynghedauw; C Delcayre
Journal:  Hypertension       Date:  1999-04       Impact factor: 10.190

7.  The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy.

Authors:  P Liao; D Georgakopoulos; A Kovacs; M Zheng; D Lerner; H Pu; J Saffitz; K Chien; R P Xiao; D A Kass; Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

8.  Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.

Authors:  Mohamed A Bayorh; A A Ganafa; N Emmett; R R Socci; D Eatman; I L Fridie
Journal:  Clin Exp Hypertens       Date:  2005-05       Impact factor: 1.749

9.  N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats.

Authors:  Marie Bourraindeloup; Christophe Adamy; Gabriele Candiani; Michel Cailleret; Marie-Claude Bourin; Thierry Badoual; Jin Bo Su; Sylviane Adubeiro; Françoise Roudot-Thoraval; Jean-Luc Dubois-Rande; Luc Hittinger; Françoise Pecker
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

10.  Scar and pulmonary expression and shedding of ACE in rat myocardial infarction.

Authors:  Roger Gaertner; Fabrice Prunier; Monique Philippe; Liliane Louedec; Jean-Jacques Mercadier; Jean-Baptiste Michel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

View more
  14 in total

Review 1.  High salt intake as a multifaceted cardiovascular disease: new support from cellular and molecular evidence.

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

2.  Diets rich in saturated fat and/or salt differentially modulate atrial natriuretic peptide and renin expression in C57BL/6 mice.

Authors:  Milton Vieira Costa; Caroline Fernandes-Santos; Tatiane da Silva Faria; Marcia Barbosa Aguila; Carlos Alberto Mandarim-de-Lacerda
Journal:  Eur J Nutr       Date:  2011-04-17       Impact factor: 5.614

3.  Serelaxin and the AT2 Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan Cilexetil.

Authors:  Yan Wang; Lei Han; Matthew Shen; Emma S Jones; Iresha Spizzo; Sarah L Walton; Kate M Denton; Tracey A Gaspari; Chrishan S Samuel; Robert E Widdop
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-23

4.  Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function.

Authors:  Hongmei Lang; Qiang Li; Hao Yu; Peng Li; Zongshi Lu; Shiqiang Xiong; Tao Yang; Yu Zhao; Xiaohu Huang; Peng Gao; Hexuan Zhang; Qianhui Shang; Daoyan Liu; Zhiming Zhu
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

5.  Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury.

Authors:  Yanfei Qi; Hongwei Li; Vinayak Shenoy; Qiuhong Li; Fong Wong; Ling Zhang; Mohan K Raizada; Colin Sumners; Michael J Katovich
Journal:  Exp Physiol       Date:  2011-10-03       Impact factor: 2.969

6.  Enhanced angiotensin-converting enzyme activity and systemic reactivity to angiotensin II in normotensive rats exposed to a high-sodium diet.

Authors:  Sandra Crestani; Arquimedes Gasparotto Júnior; Maria C A Marques; Jennifer C Sullivan; R Clinton Webb; J Eduardo da Silva-Santos
Journal:  Vascul Pharmacol       Date:  2013-12-07       Impact factor: 5.773

7.  Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.

Authors:  Basma Ismail; Rob A deKemp; Etienne Croteau; Tayebeh Hadizad; Kevin D Burns; Rob S Beanlands; Jean N DaSilva
Journal:  PLoS One       Date:  2017-05-19       Impact factor: 3.240

8.  Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis.

Authors:  Qin Shi; Jamilah Abusarah; Ghayath Baroudi; Julio C Fernandes; Hassan Fahmi; Mohamed Benderdour
Journal:  Arthritis Res Ther       Date:  2012-10-18       Impact factor: 5.156

9.  Cardiovascular effects of dietary salt intake in aged healthy cats: a 2-year prospective randomized, blinded, and controlled study.

Authors:  Valérie Chetboul; Brice Stéphane Reynolds; Emilie Trehiou-Sechi; Patrick Nguyen; Didier Concordet; Carolina Carlos Sampedrano; Isabelle Testault; Jonathan Elliott; Jérôme Abadie; Vincent Biourge; Hervé Pierre Lefebvre
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

10.  High-salt intake negatively regulates fat deposition in mouse.

Authors:  Huanxian Cui; Shuyan Yang; Maiqing Zheng; Ranran Liu; Guiping Zhao; Jie Wen
Journal:  Sci Rep       Date:  2017-05-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.